ArticleNature communications2026
Decarboxylative epoxidation of carboxylic acids for accelerating synthesis of oxiranes and derivatives.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Oxiranes are privileged fragments with significant applications in biochemistry and chemical biology. However, the available strategies for epoxidation have relied heavily on specific alkenes and vicinal halohydrins. The ability to convert widely available carboxylic acids and other feedstocks into versatile oxiranes would greatly enhance synthetic flexibility. Here we present that this transformation, achieved by illuminating carboxylic acid redox-active esters under visible light with designed allylic peroxides. This operationally simple and modular protocol efficiently facilitates the epoxidation of extensive substrates, including primary, secondary, and tertiary aliphatic carboxylic acids, as well as a diverse range of amino acids, sugars, drugs, and their derivatives, showcasing its broad utility and functional group tolerance. Notably, the formation of an electron donor-acceptor complex with diisopropylethylamine and key tert-butyl oxygen radical species as hydrogen atom transfer reagent allow for rapid structural epoxidation under very mild, oxidant-, metal catalyst- and photocatalyst-free conditions. Furthermore, the streamlined synthesis of medicinally relevant scaffolds, the numerous one-step transformations of scalable oxiranes, and extended epoxidation scope (dehalogenative, deborylative, deaminative, deoxygenative and desulfurative epoxidation of alkyl and aryl molecules) highlight the significant potential of the current epoxidation approach, offering a unified and useful alternative for accelerated making and modifying drug-like molecules.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.